MRKRHealthcareNano-Cap

Marker Therapeutics, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Marker Therapeutics, Inc. (MRKR), sourced directly from SEC EDGAR and updated as new filings are accepted.

Latest filing:

Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.

Quick Answer

Are MRKR insiders buying or selling?

Marker Therapeutics, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since May 2018, Trabud has recorded 20 Form 4 filings for MRKR: 20 buys ($111.5M) and 0 sells ($0).

Source: SEC EDGAR Form 4

Key Statistics (May 2018 – Dec 26, 2024)

Total Form 4 filings
20
SEC EDGAR
Insider filers
17
Insider buys (20)
$111.5M
Insider sells (0)
$0

Insider sentiment

Net buying

Net insider flow of $111.5M in net buying since May 2018.

Recent MRKR insider transactions

DateInsiderRoleTypeSharesPriceValueFiling
Dec 26, 2024ELMS STEVEDirectorPurchase11.1K$3.20$35.5KSEC ↗
Dec 23, 2024Forest Baskett10% OwnerPurchase554.3K$3.20$1.8MSEC ↗
Jun 9, 2023Norman David EansorDirectorPurchase14.3K$17.50$250.0KSEC ↗
May 20, 2021Frederick Gerald WassermanDirectorPurchase10.0K$2.41$24.1KSEC ↗
Mar 18, 2021Paul Edward Walker10% OwnerPurchase5.7M$1.75$10.0MSEC ↗
Mar 18, 2021Peter W. Sonsini10% OwnerPurchase5.7M$1.75$10.0MSEC ↗
Mar 18, 2021Scott D Sandell10% OwnerPurchase5.7M$1.75$10.0MSEC ↗
Mar 18, 2021Joshua Makower10% OwnerPurchase5.7M$1.75$10.0MSEC ↗
Mar 18, 2021Mohamad Makhzoumi10% OwnerPurchase5.7M$1.75$10.0MSEC ↗
Mar 18, 2021Anthony A. Florence Jr.10% OwnerPurchase5.7M$1.75$10.0MSEC ↗
Mar 18, 2021Carmen Chang10% OwnerPurchase5.7M$1.75$10.0MSEC ↗
Mar 18, 2021Ali Behbahani10% OwnerPurchase5.7M$1.75$10.0MSEC ↗
Mar 18, 2021Forest Baskett10% OwnerPurchase5.7M$1.75$10.0MSEC ↗
Mar 18, 2021New Enterprise Associates 16, L.P.10% OwnerPurchase5.7M$1.75$10.0MSEC ↗
Mar 18, 2021Wilson John RobertDirectorPurchase1.7M$1.75$3.0MSEC ↗
Mar 18, 2021Vera JuanChief Development OfficerPurchase571.4K$1.75$1000.0KSEC ↗
Mar 18, 2021Peter L. HoangPresident and CEOPurchase142.9K$1.75$250.0KSEC ↗
Mar 18, 2021ELMS STEVEDirectorPurchase1.1M$1.75$2.0MSEC ↗
Aug 15, 2019Peter L. HoangPresident and CEOPurchase10.0K$4.62$46.2KSEC ↗
May 16, 2018Eastern Capital LTD10% OwnerPurchase1.3M$2.40$3.1MSEC ↗

Showing the 20 most recent of 20 Form 4 filings for Marker Therapeutics, Inc..

Most active MRKR insiders

  • ELMS STEVE2 filings
  • New Enterprise Associates 16, L.P.2 filings
  • Peter L. Hoang2 filings
  • Ali Behbahani1 filing
  • Anthony A. Florence Jr.1 filing

Ask anything about MRKR insider activity

Use Trabud's AI agent to query Marker Therapeutics, Inc.'s Form 4 history in plain English — "Show me MRKR CEO purchases this year" or compare it against any other ticker.

Open the AI agent

MRKR insider trading FAQ

Are Marker Therapeutics, Inc. insiders buying or selling?

Marker Therapeutics, Inc. insiders reported no open-market purchases or sales in the last 12 months. Since May 2018, Trabud has recorded 20 Form 4 filings for MRKR: 20 buys ($111.5M) and 0 sells ($0). Over the full record that is net buying of $111.5M.

How many insiders trade MRKR stock?

17 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Marker Therapeutics, Inc.. The most recent filing was accepted on Dec 26, 2024.

Where does Trabud get MRKR insider trading data?

All MRKR insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Related Content